-
Feb 19, 2026, 6:00 am94 ptsHims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs. Federal regulators are seeking to rein in the online telemedicine platform, which for years has been selling a non-Food and Drug Administration (FDA) approved version of…
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.






